IBK Industrial Bank Holds Valuation but Faces Governance Risk IBK Industrial Bank rated Hold as cheap valuation is offset by China loan fraud and governance risk, causing profit decline and possible higher compliance costs. 2026년 08월 26일 English
Lotte Chemical Stock Holds Steady: Turnaround Still Needs Proof Lotte Chemical rated Hold as restructuring for Daesan integration lifts earnings but margins stay thin and ROE remains negative, so durability is unproven. 2026년 08월 24일 English
IBK Industrial Bank Shares Hold Despite Low Valuation: Key Risks IBK Industrial Bank is rated Hold: valuation looks cheap (PER 5.5) but profit fell 7.4% YoY amid flat revenue and heightened regulatory scrutiny over loan fraud. 2026년 08월 14일 English
Lotte Chemical Profitability Improves But Recovery Needs Proof Lotte Chemical has improved profitability, but analyst consensus stays Hold as margins remain thin and ROE deeply negative, suggesting gains may be temporary lag effects. 2026년 08월 11일 English
IBK Industrial Bank Earnings Hold as Profit Falls: Key Risks IBK Industrial Bank holds as net profit fell year over year despite slightly higher revenue; provisions and FX drag keep earnings quality weak, so analysts stay neutral (PER ~5.7) and upside needs stabilization. 2026년 07월 30일 English
Lotte Chemical Holds Steady on Results: What to Watch Lotte Chemical shows strong YoY earnings rebound, but margins stay very thin and ROE remains negative. With bank-guarantee-backed bond issuance and neutral analyst consensus, the stock is a Hold, not a clear buy. 2026년 07월 20일 English
Lotte Chemical Stock Holds Steady as Turnaround Faces Risks Lotte Chemical earnings improved year over year, but weak margins and credit pressure persist; with neutral Wall Street consensus and mixed targets, the stock remains a HOLD. 2026년 05월 22일 English
KB Financial Group Earnings Rise Despite Market Volatility: Buy Dip KB Financial Group is rated Buy as earnings grow steadily despite market volatility; revenue up 18.6% YoY, net income up 4.2%, and low forward PER 8.2 supports upside if macro fear eases. 2026년 05월 15일 English
Organon Stock Jumps on Sun Pharma Deal: Key Risks Ahead Organon stock is rated Hold as Sun Pharma confirmed an all-cash $14 offer. Shares surged, but weakening earnings make it a deal-and-timing risk, not fundamentals, and upside is limited near today’s price. 2026년 04월 28일 English
Quantumscape Corp Re-Rating Hinges on Eagle Ramp Proof Quantumscape trades around $7.41 with Hold consensus; earnings are still loss making with 0% margins, so investors wait for independently verified commercialization. 2026년 04월 24일 English
